Loading...

PR Information Data

130 개 8 페이지
번호 컨텐츠
25 “COVID-19 treatment needs a major shift to hyperthermia therapy.” 2024-03-12   47 (주)아디포랩스
24 AdipoLABs CEO Han Sung-ho was appointed as an advisory member of the Future Strategy Special Committee of the Constitutional Council. 2024-03-14   47 (주)아디포랩스
23 Willing to do his best until the day humanity is free from disease 2024-03-14   47 (주)아디포랩스
22 AdipoLABs and Cyberjaya University sign MOU for cancer treatment... “A great force in medical advancement” 2024-03-28   47 (주)아디포랩스
21 AdipoLABs’ ‘REMISSION 1℃’ cancer treatment effect recognized internationally 2024-03-29   46 (주)아디포랩스
20 World's first joint collaboration to overcome COVID-19 treatment, IVRA is launched. 2024-03-12   44 (주)아디포랩스
19 “Angola, no exception to the COVID-19 threat, recognizes the value of REMISSION 1℃” 2024-03-12   42 (주)아디포랩스
18 AdipoLABs seeks to have an academic collaboration for cancer treatment with University of Cyberjaya, Malaysia 2024-03-28   42 (주)아디포랩스
17 AdipoLABs signs research MOU with University of Cyber Jaya, Malaysia 2024-03-28   41 (주)아디포랩스
16 AdipoLABs signs research MOU with University of Cyber Jaya, Malaysia 2024-03-28   40 (주)아디포랩스
15 AdipoLABs launches ‘high-frequency hyperthermia cancer treatment device’ in Malaysia 2024-03-29   40 (주)아디포랩스
14 A new horizon in cancer treatment, the world is paying attention to hyperthermia cancer treatment device of ‘REMISSON 1℃’ 2024-03-29   39 (주)아디포랩스
13 “COVID-19 treatment needs a major shift to hyperthermia therapy.” 2024-03-12   38 (주)아디포랩스
12 Presentng a new direction for COVID-19 and cancer treatment 2024-03-12   38 (주)아디포랩스
11 'REMISSION 1℃’ to fight COVID-19 is exported worldwide 2024-03-12   37 (주)아디포랩스